Amphastar Pharmaceuticals, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Amphastar Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2013 to Q3 2024.
  • Amphastar Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was $40.4M, a 17.9% decline year-over-year.
  • Amphastar Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was $158M, a 16.6% increase year-over-year.
  • Amphastar Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was $138M, a 50.5% increase from 2022.
  • Amphastar Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $91.4M, a 47.1% increase from 2021.
  • Amphastar Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was $62.1M, a 4327% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $158M $40.4M -$8.79M -17.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $167M $37.9M +$11.8M +45.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-07
Q1 2024 $155M $43.2M +$17.1M +65.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-07
Q4 2023 $138M $36.2M +$2.25M +6.65% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $135M $49.2M +$33.3M +210% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $102M $26.1M +$8.78M +50.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-07
Q1 2023 $93.2M $26M +$1.78M +7.34% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-07
Q4 2022 $91.4M $33.9M +$14.2M +71.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $77.2M $15.9M -$13.7M -46.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $90.9M $17.3M +$9.58M +123% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-08
Q1 2022 $81.3M $24.3M +$19.2M +381% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-08
Q4 2021 $62.1M $19.8M +$26M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $36.1M $29.5M +$25.6M +654% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $10.5M $7.77M +$7.96M Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-08
Q1 2021 $2.5M $5.04M +$1.09M +27.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-08
Q4 2020 $1.4M -$6.27M -$5.25M -511% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 $6.65M $3.92M +$2.61M +199% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $4.04M -$192K -$48M -100% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-09
Q1 2020 $52M $3.95M +$3.08M +355% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-09
Q4 2019 $48.9M -$1.03M -$2.89M -155% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-16
Q3 2019 $51.8M $1.31M -$1.08M -45.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $52.9M $47.8M +$50.6M Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-06
Q1 2019 $2.27M $868K +$8.01M Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-06
Q4 2018 -$5.74M $1.87M +$399K +27.2% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 -$6.14M $2.39M +$2.29M +2313% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-16
Q2 2018 -$8.43M -$2.85M -$4.83M -245% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-16
Q1 2018 -$3.6M -$7.14M -$8.03M -900% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-16
Q4 2017 $4.43M $1.47M +$4.21M Oct 1, 2017 Dec 31, 2017 10-K 2018-03-14
Q3 2017 $222K $99K -$3.79M -97.5% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $4.01M $1.97M -$4.92M -71.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $8.94M $893K -$1.6M -64.1% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $10.5M -$2.74M -$10.3M -136% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-14
Q3 2016 $20.8M $3.89M +$6.9M Jul 1, 2016 Sep 30, 2016 10-K 2018-03-14
Q2 2016 $13.9M $6.9M +$13.5M Apr 1, 2016 Jun 30, 2016 10-K 2018-03-14
Q1 2016 $367K $2.49M +$3.15M Jan 1, 2016 Mar 31, 2016 10-K 2018-03-14
Q4 2015 -$2.79M $7.53M +$10.1M Oct 1, 2015 Dec 31, 2015 10-K 2017-03-15
Q3 2015 -$12.8M -$3.01M +$2.37M +44.1% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-15
Q2 2015 -$15.2M -$6.65M -$5.47M -463% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-15
Q1 2015 -$9.75M -$665K +$954K +58.9% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-15
Q4 2014 -$10.7M -$2.52M -$4.35M -238% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-15
Q3 2014 -$6.35M -$5.38M -$5.22M -3262% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-15
Q2 2014 -$1.13M -$1.18M -$8.99M -115% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-15
Q1 2014 $7.86M -$1.62M -$4M -168% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-15
Q4 2013 $11.9M $1.83M Oct 1, 2013 Dec 31, 2013 10-K 2015-03-26
Q3 2013 -$160K Jul 1, 2013 Sep 30, 2013 10-K 2015-03-26
Q2 2013 $7.81M Apr 1, 2013 Jun 30, 2013 10-K 2015-03-26
Q1 2013 $2.38M Jan 1, 2013 Mar 31, 2013 10-K 2015-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.